Related Experiment Video
Updated: Jun 14, 2025

05:18
Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
11.1K
Estimate of the Deterministic Neutron RBE for Radiation-induced Pseudo-Pelger Huët Cell Formation
R E Goans, C J Iddins1, R E Goans2
1Radiation Emergency Assistance Center/Training Site, Oak Ridge, TN.
Health Physics
|September 2, 2024
Summary
Pseudo-Pelger Huët anomaly (PPHA) in neutrophils is a new radiation biomarker. This study estimates the neutron relative biological effectiveness (RBE d) for PPHA formation, finding it 3.4 ± 0.6, aligning with current recommendations.
Area of Science:
- Radiation biology
- Hematology
- Dosimetry
Background:
- Pseudo-Pelger Huët anomaly (PPHA) in neutrophils identified as a novel radiation-induced biomarker.
- PPHA useful for immediate and retrospective radiation dosimetry.
Purpose of the Study:
- To compare PPHA cell frequency in historical radiation accidents.
- To estimate the deterministic neutron relative biological effectiveness (RBE d) for PPHA formation.
Main Methods:
- Analysis of archival peripheral blood slides from Y-12 (1958) and CARL (1971) radiation accident patients.
- Comparison of PPHA cell frequency and radiation doses (gamma and neutron).
- Calculation of neutron RBE d for PPHA formation using dose data from two distinct accident cohorts.
Main Results:
- PPHA cell frequency was analyzed in patients from the Y-12 and CARL accidents.
- Average doses were calculated for Y-12 (2.53 ± 0.14 Gy gamma + 0.90 ± 0.05 Gy neutron) and CARL (2.6 Gy gamma).
- The estimated neutron RBE d for PPHA formation was 3.4 ± 0.6, consistent with the recommended value of 3.
Conclusions:
- PPHA serves as a valuable biomarker for radiation exposure.
- The calculated neutron RBE d for PPHA formation supports its utility in mixed-field dosimetry.
- Findings validate PPHA as a tool for retrospective dosimetry in radiation accidents.

